How Immunotherapy is Changing the Cancer Treatment? [Video]

Immunotherapy was first introduced in 2012, and it was first used in melanoma.

#cancer #drmanishsinghal #immunotherapy #health #medical #cancerdoctor #oncologist

Melanoma is a skin cancer found in white-skinned people, which is also found in India, but it is very rare in India.

The survival rate was practically less than one year, that is, less than a year, 20 % of people started getting cured.

Ipilimumab

In melanoma, today, 55 % of people can be cured which is dealing with the last stage of cancer.

in stage 4, late stage cancer, 15 % of people used to get well for good, these are today’s statistics

Large Intestine Cancer, which we call MSI-High cancer, about which last to last year, there was a lot of discussion in the news. There was a medicine called Dostarlimab, about which there was a lot of marketing.

100 % response rate, MSI high. Microsatellite Instability High, in the large intestine, in the large intestine cancer.

There is one immunotherapy, Dendritic Cell Therapy, in which there is no direct approval of Dendritic Cell Therapy from any Drug Control Journal of India.

Dendritic Cell Therapy was developed in 2008,
In India, dendritic cell therapy, dendritic cell vaccine, which we know as dendritic cell vaccine or immunotherapy, this therapy is available in very few places, that is, it has been seen to be beneficial in very few places.

Currently, only one institution has its approval, and that too only in prostate, lung, ovarian, and colon cancer. In large intestine cancers, we can do dendritic cell therapy in all the failed therapies.

immunotherapy
fight cancer
cancer treatment
oncologist in Noida
cancer doctor in Noida
Dr Manish Singhal

Watch More Videos
https://youtu.be/3rNuOKdwV_o?si=uBmyszBM6sRgmBzK
https://youtu.be/_LKAAEemBqw?si=Gy9RdFY6YbzCThon
https://youtu.be/Fl7_5X0aLvs?si=ZA7ru5E6mZBngswO
https://youtu.be/zwAoV0XfGNU?si=oZ7WCN2C7hCAYxKz
https://youtu.be/zwAoV0XfGNU?si=FYOCYvISdQWupALl

I want you to understand about all these therapies and ask the person who is administering the therapy, whether it is approved by the Drug Controller General of India, is approved, or is under regulatory approval.

Will you get insurance for this, and if you don’t get it, why won’t you get it, and what are the facts behind it?

The package insert of the medical science provided by immunotherapy is given to you.

It is told about its shortcomings, its success, its success rate, its cost, and all these things are approved under regulatory approval, under ICMR and under Drug Control General of India.

So Be Aware and Don’t Get Fooled by Anybody.